Table 2.
Resistotypes of 276 S. Typhi isolates in Zimbabwe (2012–2017)
| Pattern | Number of isolates | Percentage | Resistotypes |
|---|---|---|---|
| A | 172 | 62.3 | AMP-C |
| B | 1 | 0.4 | CIP-AMP-C |
| C | 20 | 7.2 | CIP-TET-AMP-C |
| D | 1 | 0.4 | CIP-TET-AMP |
| E | 1 | 0.4 | CIP-NAL-AMP-C |
| F | 2 | 0.7 | NAL-AMP |
| G | 6 | 2.2 | NAL-AMP-C |
| H | 3 | 1.1 | TET-C |
| I | 32 | 11.6 | TET-AMP-C |
| K | 3 | 1.1 | TET-AMP |
| L | 2 | 0.7 | TET-NAL-AMP |
CIP Ciprofloxacin, TET Tetracyline, NAL Nalidixic acid, CTX Ceftriaxone, C Chloramphenicol, AMP Ampicillin, AZ Azithromycin